Zum Hauptinhalt springenSkip to page footer

Links zu Publikationen 2026

Publikationen 2026

1. 

Low Energy and Protein Intake in Brain Tumor Patients Despite Higher Adiposity: A Comparative Study with Gastrointestinal Cancer. 

Povazay I, Burgard L, Herrmann HJ, Neurath MF, Eyüpoglu IY, Zopf Y.

Nutrients. 2026 Mar 26;18(7):1051. doi: 10.3390/nu18071051.

PMID: 41978102      

2. 

Transforming tumor cells into professional antigen-presenting cells using poly(β-amino ester) nanoparticles to deliver CD80-encoding mRNA. 

Binder AK, Bremm F, Feuchter N, Torres-Coll A, Kübel S, Berking C, Borrós S, Fornaguera C, Schaft N, Dörrie J.

Nanoscale Horiz. 2026 Apr 12. doi: 10.1039/d5nh00667h. Online ahead of print.

PMID: 41966140      

3. 

Hydrogen sulfide as a therapeutic candidate in diabetic retinopathy: a new perspective from gas medicine. 

Xue M, Dai W, Yuan S, Günther C.

Med Gas Res. 2026 Apr 11. doi: 10.4103/mgr.MEDGASRES-D-25-00186. Online ahead of print.

PMID: 41964596      No abstract available. 

4. 

CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome. 

Korte IK, Kharboutli S, Völkl S, Heberling L, Scholz JK, Pfeiffer H, Strobel J, Harrer T, Kretschmann S, Vasova I, Gerbitz A, Achenbach S, Spriewald B, Krause S, Gutsche K, von Bonin M, Röllig C, Aigner M, Mackensen A, Müller F.

Med. 2026 Apr 9:101075. doi: 10.1016/j.medj.2026.101075. Online ahead of print.

PMID: 41962541      

5. 

Universal high-sensitivity CAR T-cell monitoring by targeting linker sequences. 

Schwingen NR, Meretuk L, Aigner M, Kretschmann S, Scholz JK, Gsottberger F, Harrer DC, Dingfelder J, Lutzny-Geier G, Kharboutli S, Mackensen A, Müller F, Völkl S.

Front Immunol. 2026 Mar 25;17:1787951. doi: 10.3389/fimmu.2026.1787951. eCollection 2026.

PMID: 41958667      Free PMC article.      

6. 

Why we need to maintain a critical view on big data and artificial intelligence predictions. 

Temiz A, Tascilar K.

Curr Opin Immunol. 2026 Apr 8;100:102776. doi: 10.1016/j.coi.2026.102776. Online ahead of print.

PMID: 41955863      Review.      

7. 

Viral dynamics of the Respiratory Syncytial Virus during experimental human challenge: insights for transmission and protection. 

Schumer C, Mann AJ, Fourati S, Lukas P, Graw F, Catchpole A, Guedj J.

J Infect Dis. 2026 Apr 7:jiag206. doi: 10.1093/infdis/jiag206. Online ahead of print.

PMID: 41954922      

8. 

18F-Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis. 

Quinn KA, Tan S, Verdijk P, Okonkwo L, Samson M, Blockmans D, Makhzoum JP, Cid MC, Henes J, Schönau V, Ahlman MA, Grayson PC.

Arthritis Rheumatol. 2026 Apr 6. doi: 10.1002/art.70166. Online ahead of print.

PMID: 41940456      

9. 

AnnexinA1-Dectin 1 axis is a key regulator of osteoclastogenesis underlying irradiation induced bone loss in male mice. 

Guliyeva G, Takile FNF, Stallfort V, Derer A, Frey B, Gupta P, Weber M, Trumet L, Schett G, Bozec A, Grötsch B.

J Bone Miner Res. 2026 Apr 2:zjag062. doi: 10.1093/jbmr/zjag062. Online ahead of print.

PMID: 41925240      

10. 

Pathophysiology of colitis-associated colorectal cancer. 

Neufert C, Neurath MF.

Nat Rev Gastroenterol Hepatol. 2026 Apr 1. doi: 10.1038/s41575-026-01197-6. Online ahead of print.

PMID: 41922722      Review.      

11. 

TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation. 

Ghirotto B, Gonçalves LE, Ruder V, James C, Gerasimova E, Rizo T, Wend H, Farrell M, Gerez JA, Prymaczok NC, Kuijs M, Shulman M, Hartebrodt A, Prots I, Gessner A, Vieth M, Zunke F, Winkler J, Blumenthal DB, Theis FJ, Riek R, Günther C, Neurath M, Gupta P, Winner B.

Nat Commun. 2026 Apr 1;17(1):3217. doi: 10.1038/s41467-026-71317-y.

PMID: 41922384      Free PMC article.      

12. 

Treatment with Sildenafil Promotes Angiogenesis and Modulates Immune Response in Ischemic Muscle Tissue. 

Kuhs A, Bobrowski L, Elbs K, Kübler M, Götz P, Arnholdt C, Lasch M, Deindl E.

Curr Issues Mol Biol. 2026 Mar 6;48(3):283. doi: 10.3390/cimb48030283.

PMID: 41899435      Free PMC article.      

13. 

Interferon-β and FTY720 ameliorate progressive CNS inflammation via SOCS1-associated astrocyte signaling. 

Tsaktanis T, Beyer T, Nirschl L, Rotaru AI, Engleitner T, Öllinger R, Zuber F, Peter A, Zissler J, Tschurl V, Linnerbauer M, Lößlein L, Vandrey O, Rad R, Korn T, Rothhammer V.

Sci Rep. 2026 Mar 25;16(1):9851. doi: 10.1038/s41598-026-45303-9.

PMID: 41882284      Free PMC article.      

14. 

Increased synovial and entheseal fibroblast activation detected by 68Ga-FAPI-PET/CT is associated with the development of psoriatic arthritis in psoriasis patients with arthralgia. 

Corte G, Atzinger A, Noversa de Sousa R, Mutlu MY, Temiz A, Bayat S, Raimondo MG, Ramming A, Sticherling M, Schmidkonz C, Kuwert T, Schett G, Tascilar K, Fagni F.

RMD Open. 2026 Mar 23;12(1):e006567. doi: 10.1136/rmdopen-2025-006567.

PMID: 41871918      Free PMC article.      

15. 

Human blood vessel organoids recapitulate key mechanisms of transition from vasculopathy to fibrosis in systemic sclerosis. 

Xiao Y, Hong X, Zhi L, Li YN, Regensburger M, Marxreiter F, Görg B, Koziel S, Györfi AH, Filla T, Bruch PM, Tripal P, Adjaye J, Dietrich S, Winkler J, Distler JHW, Matei AE.

Ann Rheum Dis. 2026 Mar 21:S0003-4967(26)00136-6. doi: 10.1016/j.ard.2026.02.021. Online ahead of print.

PMID: 41866288      

16. 

Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathology. 

Petzold A, Wessely A, Schliep S, Jiang H, Tran M, Koch EA, Peng T, Starz H, Berking C, Marr C, Heppt MV.

J Pathol Clin Res. 2026 Mar;12(2):e70082. doi: 10.1002/2056-4538.70082.

PMID: 41841638      

17. 

Paneth cells as orchestrators of epithelial barrier defense and emerging therapeutic targets in inflammatory bowel disease. 

Erkert L, Haag LM, Becker C.

Semin Immunopathol. 2026 Mar 16;48(1):1. doi: 10.1007/s00281-026-01068-x.

PMID: 41838175      Free PMC article.      Review.      

18. 

mRNA-based CAR T cell engineering: Unmodified mRNA enables high CAR expression without innate immune activation in T cells. 

Kahwaji N, Kotzian N, Prinz JM, Pu Y, Kath J, Picht S, Hiller AL, Klaas A, Dunne CM, Launspach M, Palmowski A, Kleyer A, Simon DN, Wagner DL, Pichon C, Krönke G, Schmueck-Henneresse M, Volk HD, Gossen M, Drzeniek NM.

Mol Ther Nucleic Acids. 2026 Jan 5;37(1):102805. doi: 10.1016/j.omtn.2025.102805. eCollection 2026 Mar 12.

PMID: 41834823      Free PMC article.      

19. 

Spatiotemporal molecular profiling of macrophage-fibroblast crosstalk defines checkpoints orchestrating onset and resolution of inflammation. 

Weishaupt K, Chambers D, Dzamukova M, Androšević I, Auger JP, Hueser D, Trzebanski S, Ramming A, Grüneboom A, Schett G, Jung S, Hoffmann MH, Krönke G.

Cell Rep. 2026 Mar 24;45(3):117091. doi: 10.1016/j.celrep.2026.117091. Epub 2026 Mar 14.

PMID: 41832953      

20. 

In-Person vs. Virtual: A Comparative Study of Teaching Methods in Nutritional Medicine.  

Trutwin BCR, Eilers J, Herrmann HJ, Neurath MF, Kohl M, Zopf Y, Burgard LC.

Nutrients. 2026 Mar 3;18(5):821. doi: 10.3390/nu18050821.

PMID: 41829991      Free PMC article.      Clinical Trial.      

21. 

Variability in BIA-Derived Muscle Mass Estimates: Device Choice Impacts Diagnostic Classification. 

Burgard LC, Goldschmidt S, Ohse VA, Herrmann HJ, Reljic D, Neurath MF, Zopf Y.

Nutrients. 2026 Feb 26;18(5):767. doi: 10.3390/nu18050767.

PMID: 41829937      Free PMC article.      

22. 

Metabolically reprogrammed eosinophils impair T cell immunity and cause chronic skin infection. 

Barinberg D, Sebald H, Gold T, Rai B, Radtke D, Lerm D, Voehringer D, Jantsch J, Wirtz S, Antonova AU, Colonna M, Bogdan C, Schleicher U.

EMBO Mol Med. 2026 Mar 11. doi: 10.1038/s44321-026-00392-x. Online ahead of print.

PMID: 41813911      

23. 

MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease. 

Pollinger L, Greve JN, Grosch M, Kaliman S, Abuhattum S, Kräter M, Brauer I, Schaefer JT, Pasutto F, Wiesener A, Wopperer FJ, Kolb C, Lehmann CHK, Hoerning A, Daniel C, Amann K, Guck J, Schiffer M, Manstein DJ, Wiesener MS, Jobst-Schwan T.

Kidney Int Rep. 2026 Feb 3;11(4):106343. doi: 10.1016/j.ekir.2026.106343. eCollection 2026 Apr.

PMID: 41799362      Free PMC article.      

24. 

Beyond mobility: A prospective study on diet and metabolism in hereditary spastic paraplegia. 

Erhardt C, Spatz IT, Herrmann HJ, Kohl Z, Zopf Y, Gassner H, Winkler J, Regensburger M.

Metab Brain Dis. 2026 Mar 3;41(1):45. doi: 10.1007/s11011-026-01815-x.

PMID: 41774218      Free PMC article.      

25. 

Long-term osteoprotective effects of IL-17A blockade with secukinumab in psoriatic arthritis: data from the PSARTROS-II study. 

Schuster L, Temiz A, Mutlu MY, Tascilar K, Bayat S, Corte G, Rech J, Hueber A, Liphardt AM, Kleyer A, Simon D, Roemer F, Schett G, Fagni F.

RMD Open. 2026 Feb 25;12(1):e005857. doi: 10.1136/rmdopen-2025-005857.

PMID: 41741168      Free PMC article.      

26. 

CAR T-cell therapy in autoimmune skin disease. 

Schett A, Schett G.

J Eur Acad Dermatol Venereol. 2026 Mar;40(3):328-330. doi: 10.1111/jdv.70178.

PMID: 41738499      No abstract available. 

27. 

Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanoma. 

Lodde G, Dollani J, Galetzka W, Mohr P, Meier F, Gutzmer R, Weichenthal M, Utikal J, Herbst R, Leiter U, Pföhler C, Schilling B, Terheyden P, Berking C, Sucker A, Stang A, Rambow F, Tilkorn D, Roesch A, Zaremba A, Zimmer L, Tasdogan A, Schadendorf D, Ugurel S, Griewank K, Livingstone E.

Br J Dermatol. 2026 Feb 20:ljaf499. doi: 10.1093/bjd/ljaf499. Online ahead of print.

PMID: 41719057      

28. 

Geometry of disordered porous environments regulates cell migration. 

Würthner L, Graw F.

Phys Rev E. 2026 Jan;113(1-1):014407. doi: 10.1103/hvtd-qwp1.

PMID: 41715819      

29. 

Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases. 

Düsing C, Györfi AH, Stütz AN, Lahu LM, Deicher FS, Li YN, Bruch PM, Matei AE, Micu A, Filla T, Koziel S, Hölscher AS, Röhrich M, Lorenz HM, Cramer M, Antoch G, Timm J, Abusabha Y, Ruck T, Homey B, Kreuter A, Buehring B, Radujkovic A, Heußel CP, Hagen M, Grieshaber-Bouyer R, Schett G, Brunn A, Dietrich S, Merkt W, Distler JHW.

Nat Med. 2026 Feb 19. doi: 10.1038/s41591-026-04238-4. Online ahead of print.

PMID: 41714747      

30. 

Vision transformer-based diagnosis of psoriasis and eczema in whole-slide histology.  

Rivera Monroy LC, Petzold A, Sari M, Breininger K, Maier A, Vera-Gonzalez J, Erdmann M, Schliep S, Drexler K, Niebel D, Schreml S, Hayani KM, Aebischer V, Braun SA, Schmidle P, Metze D, Sticherling M, Berking C, Koch EAT, Heppt MV.

Virchows Arch. 2026 Feb 20. doi: 10.1007/s00428-026-04445-x. Online ahead of print.

PMID: 41714431      

31. 

Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis. 

Gabel M, Knauss A, Liu Y, Mohamed Abdou M, Kaufmann C, Loges L, Stürzl M, Schürmann S, Waldner MJ, Neurath MF, Weigmann B.

Front Med (Lausanne). 2026 Feb 2;13:1750826. doi: 10.3389/fmed.2026.1750826. eCollection 2026.

PMID: 41704697      Free PMC article.      

32. 

A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis. 

Makhzoum JP, Cid MC, Samson M, Henes J, Schönau V, Espigol-Frigole G, Ross C, Ahlman MA, Hsu MC, Li S, Verdijk P, Okonkwo L, Grayson PC, Blockmans D.

Ann Rheum Dis. 2026 Feb 12:S0003-4967(26)00013-0. doi: 10.1016/j.ard.2026.01.009. Online ahead of print.

PMID: 41688258      

33. 

Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review. 

Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, Friedrich M, Ghosh S, Iacucci M, Jairath V, Kaser A, Leong RW, Neurath MF, Pierre N, Pohin M, Rath T, Rivière P, Travis S, Westcott J, Zeissig S, Peyrin-Biroulet L.

Am J Physiol Gastrointest Liver Physiol. 2026 Apr 1;330(4):G424-G458. doi: 10.1152/ajpgi.00447.2025. Epub 2026 Feb 12.

PMID: 41677575      Review.      

34. 

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease. 

Tsaktanis T, Rudtke L, Ammon L, Mestermann S, Rothhammer V, Lewczuk P, Maler JM, Kornhuber J, Oberstein TJ.

Alzheimers Res Ther. 2026 Feb 6;18(1):47. doi: 10.1186/s13195-026-01978-w.

PMID: 41652618      Free PMC article.      

35. 

Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach. 

Sari M, Schliep S, Petzold A, Kiesewetter F, Erdmann M, Sticherling M, Berking C, Heppt MV, Koch EAT.

J Cutan Pathol. 2026 May;53(5):444-453. doi: 10.1111/cup.70064. Epub 2026 Feb 5.

PMID: 41645409      Free PMC article.      

36. 

Simulation-based inference of cell migration dynamics in complex spatial environments. 

Arruda J, Alamoudi E, Mueller R, Vaisband M, Molkenbur R, Merrin J, Kiermaier E, Hasenauer J.

NPJ Syst Biol Appl. 2026 Jan 29;12(1):20. doi: 10.1038/s41540-026-00648-9.

PMID: 41611727      Free PMC article.      

37. 

Repurposing PDE5-Inhibitors: Sildenafil Drives Arteriogenesis via Localized Regenerative Inflammation. 

Elbs K, Bobrowski L, Arnholdt C, Kübler M, Götz P, Rohrmoser MR, Merkus D, Lasch M, Deindl E.

Int J Mol Sci. 2026 Jan 19;27(2):985. doi: 10.3390/ijms27020985.

PMID: 41596630      Free PMC article.      

38. 

Molecular stratification and transcriptome-guided therapeutics in systemic lupus erythematosus with insufficient treatment response. 

Beretta L, Chan CWS, Moysidou GS, Nöthling DM, Ainatzoglou A, Zoli A, Katechis S, Fanouriakis A, Bozec A, Sidiropoulos P, Bergmann C, Boumpas DT, Schett G, Bertsias G, Garantziotis P.

J Autoimmun. 2026 Mar;159:103525. doi: 10.1016/j.jaut.2026.103525. Epub 2026 Jan 21.

PMID: 41570368      

39. 

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy. 

Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, Karacondi K, Zent M, Konen FF, Sühs KW, Meuth SG, Pawlitzki M, Warnke C, Ayzenberg I, Schneider R, Helmchen C, Brüggemann N, Klebe S, Hildner M, Grefkes C, Nitsch L, Hühnchen P, Böltz S, Alt L, Tumani H, Kleinschnitz C, Pul R, Grauer O, Clifford D, Gnanapavan S, Wicklein R, Perpoint T, Beudel M, Del Bello A, Rauer S, Wiendl H, Jelcic I, Gasnault J, Cimini E, Antinori A, Pinnetti C, Pourcher V, Weiss N, Lambert N, Maecker-Kolhoff B, Höglinger GU, Zahraeifard S, Cortese I, Eiz-Vesper B, Martin-Blondel G, Skripuletz T; Immunotherapy for PML Study Group.

JAMA Neurol. 2026 Mar 1;83(3):280-289. doi: 10.1001/jamaneurol.2025.5318.

PMID: 41557340      Free PMC article.      

40. 

Contemporary 0.55 T MRI to visualize interstitial lung disease - An exploratory study. 

Bayerl N, Mathy CS, Bergmann C, Bäuerle T, Adams LC, Nagel AM, Distler JHW, Gerhalter T, Uder M, Heiss R, Ellmann S.

Eur J Radiol Open. 2026 Jan 5;16:100720. doi: 10.1016/j.ejro.2025.100720. eCollection 2026 Jun.

PMID: 41550670      Free PMC article.      

41. 

Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'. 

Tur C, Eckstein M, Rauber S, Schett G, Bozec A, Raimondo MG.

Ann Rheum Dis. 2026 Jan;85(1):e1-e2. doi: 10.1016/j.ard.2025.09.008. Epub 2025 Nov 12.

PMID: 41539838      No abstract available. 

42. 

A centrally positioned cluster of multiple centrioles in antigen-presenting cells fosters T cell activation. 

Stötzel I, Weier AK, Sarkar A, Som S, Bach L, Konopka P, Miková E, Ghosh S, Böthling J, Homrich M, Schaedel L, Kazmaier U, Symeonidis K, Ebner S, Weidner P, Abdullah Z, Meissner F, Uderhardt S, Hons M, Baumjohann D, Paul R, Rieger H, Kiermaier E.

Nat Commun. 2026 Jan 13;17(1):536. doi: 10.1038/s41467-026-68286-7.

PMID: 41530195      Free PMC article.      

43. 

Definition of predictive and prognostic immune biomarkers for salivary gland cancer from the intratumoural and systemic immune status: detailed protocol of the prospective, observatory ImmoGlandula study. 

Donaubauer AJ, Frey B, Agaimy A, Lange F, Mogge L, Fietkau R, Iro H, Munoz LE, Weber M, Kesting M, Gaipl US, Haderlein M, Müller S.

BMJ Open. 2026 Jan 12;16(1):e100021. doi: 10.1136/bmjopen-2025-100021.

PMID: 41526019      Free PMC article.      

44. 

Epigenetic Modulation of IL-7 and IL-10: Toward Personalized Immune Therapies in Viral Epidemics. 

Yulugkural Z, Yildiz M, Topcu E, Elmaslar Mert HT, Temiz A.

J Immunol Res. 2026 Jan 8;2026:9467657. doi: 10.1155/jimr/9467657. eCollection 2026.

PMID: 41523740      Free PMC article.      

45. 

Intestinal Sclerostin Deficiency Links Gut Dysbiosis to Altered Serotonin Homeostasis in Axial Spondyloarthritis. 

Mauro D, Bergot AS, Guggino G, Salzillo A, Forte G, Ciancio A, Rizzo A, Raimondo S, Lentini L, Gandolfo S, Kim SP, Wong C, De Marino B, Milling S, Alessandro R, Panarese I, Riddle RC, Zaiss MM, McGonagle D, Thomas R, Ciccia F.

Inflammation. 2026 Jan 10;49(1):38. doi: 10.1007/s10753-025-02393-3.

PMID: 41518441      Free PMC article.      

46. 

esloco: simulation-based estimation of local coverage in long-read DNA sequencing. 

Weich A, Lischer C, Vera J.

Bioinformatics. 2026 Jan 3;42(2):btag009. doi: 10.1093/bioinformatics/btag009.

PMID: 41512287      Free PMC article.      

47. 

Mucosal innate immune activation as the trigger to Prevotella species-induced arthritis in genetically resistant mice. 

Maeda Y, Rabenow M, Xiang W, Schmid E, Otterbein N, Gimaev I, Amend L, Riedinger L, Ehnes L, Miyagawa I, Sarfati I, Lesker TR, Danzer H, Sarter K, Dürholz K, Schälter F, Bao L, Wirtz S, Arnold P, Hofmann J, Pischetsrieder M, Sjöberg D, Svärd A, Kastbom A, Schett G, Strowig T, Zaiss MM.

Cell Rep. 2026 Jan 27;45(1):116755. doi: 10.1016/j.celrep.2025.116755. Epub 2026 Jan 5.

PMID: 41499240      

48. 

The role of the TIM-3 receptor in inflammatory bowel disease and autoimmunity: implications for TIM-3 and TCR crosstalk. 

Gabel M, Knauss A, Neurath MF, Weigmann B.

J Mol Med (Berl). 2026 Jan 2;104(1):20. doi: 10.1007/s00109-025-02631-z.

PMID: 41483156      Free PMC article.      Review.      

49. 

Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to joints. 

Raimondo MG, Mohammadian H, Angeli MR, Alivernini S, Fedorchenko V, Huang K, Demmler R, Rhein P, Xu C, Li YN, Micheroli R, Winter Z, Rigau AR, Anchang CG, Soare A, Luber M, Labinsky H, Chang J, Günther C, Fearon U, Veale DJ, Ciccia F, Rech J, Sticherling M, Bäuerle T, Distler JHW, Kurowska-Stolarska MS, Mack M, Ekici AB, Croft AP, Distler O, Maric HM, Ospelt C, Cañete JD, D'Agostino MA, Schett G, Rauber S, Ramming A.

Nat Immunol. 2026 Jan;27(1):35-47. doi: 10.1038/s41590-025-02351-z. Epub 2026 Jan 2.

PMID: 41482544      Free PMC article.      

50. 

T cell engagers emerge as a compelling therapeutic modality. 

Baeuerle PA, Sauer K, Grieshaber-Bouyer R, Michaelson JS.

J Exp Med. 2026 Feb 2;223(2):e20251652. doi: 10.1084/jem.20251652. Epub 2025 Dec 26.

PMID: 41474966      Review.      

51. 

Author Correction: E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis. 

Patankar JV, Müller TM, Kantham S, Acera MG, Mascia F, Scheibe K, Mahapatro M, Heichler C, Yu Y, Li W, Ruder B, Günther C, Leppkes M, Mathew MJ, Wirtz S, Neufert C, Kühl AA, Paquette J, Jacobson K, Atreya R, Zundler S, Neurath MF, Young RN, Becker C.

Nat Cell Biol. 2026 Feb;28(2):379. doi: 10.1038/s41556-025-01863-y.

PMID: 41429937      No abstract available. 

52. 

New insights into Th9 cells in inflammatory bowel diseases. 

Neurath MF.

Semin Immunol. 2026 Mar;81:102013. doi: 10.1016/j.smim.2025.102013. Epub 2025 Dec 16.

PMID: 41406701      Review.      

53. 

Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy. 

Dugas-Breit S, Forschner A, Erdmann M, Gutzmer R, Kähler KC, Holst I, Brekner A, Franklin C, Sindrilaru A, Zimmer L, Heinzerling L, Utikal J, Meier F, Bender A, Berking C, Garbe C, Weichenthal M, Schadendorf D, Hauschild A, Gschnell M, Mohr P, Hassel JC.

Eur J Cancer. 2026 Jan 17;233:116149. doi: 10.1016/j.ejca.2025.116149. Epub 2025 Nov 29.

PMID: 41385939      

54. 

Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy. 

Freitag M, Kolb P, Falcone V, Claus M, Schröder P, Andreeva I, Rodon L, Ewald M, Deicher FS, Stütz AN, Distler JHW, Blank N, Grieshaber-Bouyer R, Muñoz LE, Lorenz HM, Schett G, Merkt W.

Rheumatology (Oxford). 2026 Mar 5;65(3):keaf627. doi: 10.1093/rheumatology/keaf627.

PMID: 41335463      Free PMC article.      

55. 

Neutrophil Transmigration Analyses for Multiplexed Drug Screening and In Vivo Like Application Testing Using an Organ on a Chip Model. 

Reichardt CM, Muñoz LE.

Methods Mol Biol. 2026;2990:97-104. doi: 10.1007/978-1-0716-4997-8_8.

PMID: 41269551      

56. 

Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis. 

Atreya R, Neurath MF.

Lancet Gastroenterol Hepatol. 2026 Jan;11(1):5-6. doi: 10.1016/S2468-1253(25)00330-9. Epub 2025 Nov 13.

PMID: 41242335      No abstract available. 

57. 

Confounding by indication in observational studies investigating glucocorticoid-associated adverse events in patients with rheumatoid arthritis: a systematic literature review including an assessment of E-values. 

Palmowski A, Beenken AE, Pankow A, Oldenkott J, Käding H, Wiebe E, Boyadzhieva Z, Matteson EL, Minopoulou I, Witte T, Simon D, Boers M, Kleyer A, Buttgereit F.

Ann Rheum Dis. 2026 Mar;85(3):580-583. doi: 10.1016/j.ard.2025.10.008. Epub 2025 Nov 13.

PMID: 41238491      No abstract available. 

58. 

Lifestyle medicine in Parkinson's disease. 

Süß P, Regensburger M, Gassner H, Winkler J.

J Neural Transm (Vienna). 2026 Feb;133(2):279-295. doi: 10.1007/s00702-025-03059-y. Epub 2025 Nov 12.

PMID: 41222709      Free PMC article.      Review.      

59. 

Myosin II regulates cellular thermo-adaptability and the efficiency of immune responses. 

Company-Garrido I, Zurita Carpio A, Colomer-Rosell M, Ciraulo B, Molkenbur R, Lanzerstorfer P, Pezzano F, Agazzi C, Hauschild R, Jain S, Jacques JM, Venturini V, Knapp C, Xie Y, Merrin J, Weghuber J, Schaaf M, Quidant R, Kiermaier E, Ortega Arroyo J, Ruprecht V, Wieser S.

Dev Cell. 2026 Feb 11;61(2):356-371.e12. doi: 10.1016/j.devcel.2025.10.006. Epub 2025 Nov 4.

PMID: 41192429      

60. 

CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation.  

Garantziotis P, Auth J, Schett G, Bergmann C.

Curr Opin Rheumatol. 2026 Jan 1;38(1):60-68. doi: 10.1097/BOR.0000000000001133. Epub 2025 Oct 30.

PMID: 41185148      Review.      

61. 

Entheseal tissue signature in response to IL-17A inhibition in psoriatic arthritis: results from the EBIO entheseal biopsy study. 

Raimondo MG, Mohammadian H, Rauber S, Alivernini S, Fedorchenko V, Rigau AR, Angeli MR, Fagni F, Corte G, Tascilar K, Labinsky H, Ramming AM, Roemer F, Rech J, Braeuer L, D'Agostino MA, Schett G, Pachowsky M, Kleyer A, Ramming A.

Ann Rheum Dis. 2026 Feb;85(2):285-296. doi: 10.1016/j.ard.2025.08.032. Epub 2025 Oct 16.

PMID: 41107119      

62. 

Predicting Treatment Outcomes in Patients With Psoriatic Arthritis or Axial Spondyloarthritis: An Artificial Intelligence-Driven Approach. 

Vodenčarević A, Brandt-Juergens J, Bär S, Kästner P, Köhm M, Simon D, Behrens F, Glassen T, Gmeiner B, Peterlik D, Kiltz U.

J Rheumatol. 2026 Feb 1;53(2):152-161. doi: 10.3899/jrheum.2025-0327.

PMID: 41093647      

63. 

[Amniotic membrane-covered bioimplants for treatment of severe pseudomembranous keratoconjunctivitis in two patients with erythema exsudativum multiforme following pneumonia caused by Mycoplasma pneumoniae]. 

Voulgari T, Heppt MV, Steinhorst K, Kruse FE, Weller JM.

Ophthalmologie. 2026 Jan;123(1):67-70. doi: 10.1007/s00347-025-02317-4. Epub 2025 Aug 29.

PMID: 40879749      German.      No abstract available. 

64. 

Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus. 

Didona D, Hudemann C, Garn H, Krzikalla D, Wang SH, Hinterseher J, Volkmann K, Polakova A, Zakrzewicz A, Feldhoff S, Tikkanen R, Digigow R, Pfützner W, Santos A, Zimmer CL, Hahmann M, Harnisch S, Rösch S, Huguenin S, Eming R, Hahn M, Schauer F, Antiga E, Senatore S, Maglie R, Täubel J, Ghoreschi K, Meier K, Solimani F, Sticherling M, Sollfrank L, Günther C, Steinbrink K, Magnolo N, van Schaick E, Asnaghi V, Zollmann FS, Pohlner J, Hummel J, Sandbrink R, de Min C, Fleischer S, Möbs C, Hertl M.

Br J Dermatol. 2026 Jan 6;194(1):86-98. doi: 10.1093/bjd/ljaf311.

PMID: 40795222      Clinical Trial.      

65. 

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus. 

Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A; PRECISESADS Clinical Consortium; Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I.

Ann Rheum Dis. 2026 Jan;85(1):153-163. doi: 10.1016/j.ard.2025.06.2132. Epub 2025 Jul 23.

PMID: 40701862      

66. 

Bioengineered Bacterial Vesicles and Biomimetic Hybrids Eliminate Biofilms and Balance the Gut Microbiome. 

Pourtalebi Jahromi L, Kronast B, Munkert J, Sana L, Koch M, Danzer H, Dormeyer S, Jiang S, Herrmann F, Weiler M, Kashkanova A, Sandoghdar V, Zaiss MM, Fuhrmann G.

Small. 2026 Mar;22(16):e2502551. doi: 10.1002/smll.202502551. Epub 2025 Jul 22.

PMID: 40693324      Free PMC article.      

67. 

Calibration-free Laser-induced Breakdown Spectroscopy (CF-LIBS): Plasma criteria for porcine tissue. 

Böhmer E, Degelmann LS, Thoma OM, Waldner MJ, Mehari F, Klämpfl F, Hohmann M, Schmidt M.

Talanta. 2026 Jan 1;297(Pt A):128545. doi: 10.1016/j.talanta.2025.128545. Epub 2025 Jul 15.

PMID: 40680366